| J9271 | Injection, pembrolizumab, 1 mg | 6,400 | $40 | $262.4K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,400 | $40 | $205.2K |
| J0897 | Injection, denosumab, 1 mg | 2,280 | $20 | $38.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 280 | $130 | $36K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $100 | $21.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 120 | $90 | $10.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $130 | $10.4K |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 40 | $210 | $8.9K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,230 | $10 | $7.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 30 | $160 | $5.1K |